Novartis has agreed to buy Regulus Therapeutics for up to $1.7 billion, giving the Swiss drugmaker access to an experimental ...

The active ingredient in the popular weight loss drug Wegovy may help treat a type of fatty liver disease, according to a new ...

Currently, doctors sometimes use a drug called spironolactone to treat this condition. It’s a medication that’s been around ...

The international community has a golden opportunity to start reining in the escalating, mostly ignored global burden of ...

Compare Dialysis Centers examined CDC data and other sources to explore kidney disease risk factors and why the condition has ...

Kidney disease ranges from mild dysfunction treatable with medication to severe cases requiring dialysis or transplant. Acute ...

Diabetic kidney disease is chronic kidney disease that occurs as a complication of diabetes. Learn about its signs and ...

Swiss pharmaceutical giant Novartis is poised to expand its profile in the San Diego area, announcing plans to acquire ...

The latest findings provide reassurance for nephrologists who may be hesitant to prescribe these types of medications.

Novartis has agreed to acquire US-based Regulus Therapeutics and its oligonucleotide, farabursen, to bolster its renal ...